Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Neurofilament accumulation disrupts autophagy in giant axonal neuropathy
Jean-Michel Paumier, James Zewe, Chiranjit Panja, Melissa R. Pergande, Meghana Venkatesan, Eitan Israeli, Shikha Prasad, Natasha Snider, Jeffrey N. Savas, Puneet Opal
Jean-Michel Paumier, James Zewe, Chiranjit Panja, Melissa R. Pergande, Meghana Venkatesan, Eitan Israeli, Shikha Prasad, Natasha Snider, Jeffrey N. Savas, Puneet Opal
View: Text | PDF
Research Article Cell biology Neuroscience

Neurofilament accumulation disrupts autophagy in giant axonal neuropathy

  • Text
  • PDF
Abstract

Neurofilament accumulation is associated with many neurodegenerative diseases, but it is the primary pathology in giant axonal neuropathy (GAN). This childhood-onset autosomal recessive disease is caused by loss-of-function mutations in gigaxonin, the E3 adaptor protein that enables neurofilament degradation. Using a combination of genetic and RNA interference approaches, we found that dorsal root ganglia from mice lacking gigaxonin have impaired autophagy and lysosomal degradation through 2 mechanisms. First, neurofilament accumulations interfere with the distribution of autophagic organelles, impairing their maturation and fusion with lysosomes. Second, the accumulations attract the chaperone 14-3-3, which is responsible for the proper localization of the key autophagy regulator transcription factor EB (TFEB). We propose that this dual disruption of autophagy contributes to the pathogenesis of other neurodegenerative diseases involving neurofilament accumulations.

Authors

Jean-Michel Paumier, James Zewe, Chiranjit Panja, Melissa R. Pergande, Meghana Venkatesan, Eitan Israeli, Shikha Prasad, Natasha Snider, Jeffrey N. Savas, Puneet Opal

×

Figure 8

Autophagic flux is dysregulated in GAN.

Options: View larger image (or click on image) Download as PowerPoint
Autophagic flux is dysregulated in GAN.
(A) The autophagic receptor p62 ...
(A) The autophagic receptor p62 is increased in Gan-null DRG cultures. Representative fluorescence images of control and Gan-null DRG neurons costained for p62 and NFL, with mean intensity quantified. Scale bar: 30 μm. Insets are shown at ×3 magnification. (B) Western blots show an increase in p62 and a reduction in LC3 isoforms LC3-I and LC3-II; quantified in adjacent histograms. (C) Autophagic flux is downregulated in Gan-null DRG cultures. DRG neurons from WT and Gan-null mice were treated with vehicle, bafilomycin A1, rapamycin, and both drugs as shown. Basal autophagic flux was calculated as the difference between the levels of LC3-II expression (normalized to GAPDH as a loading control) in the bafilomycin A1 treatment in each experimental condition compared to its levels treated with vehicle control. Autophagic flux under rapamycin stimulation is shown alongside. Autophagic flux induced by rapamycin was calculated as the difference between the levels of normalized LC-II expression in the combination rapamycin and bafilomycin A1 treatment and those treated with rapamycin alone. n = 3, with sample Western blot of 1 representative experiment shown. The LC3 blot is shown at short and long exposure to clearly display bands. Quantitative data are presented as mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001 by 2-tailed, unpaired Student’s t test.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts